ROBERT LEHR: Open Payments
NPI 1619901634 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,754 in 143 payments from 17 companies in 2025. Trend: 2023 $2,150 · 2024 $2,139 · 2025 $2,754
Food & beverage: $2,670Education: $84
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 28 | $476 |
| GENZYME CORPORATION | 16 | $435 |
| Janssen Biotech, Inc. | 17 | $402 |
| Regeneron Healthcare Solutions, Inc. | 12 | $260 |
| ABBVIE INC. | 16 | $252 |
| Galderma Laboratories, L.P. | 18 | $189 |
| UCB, Inc. | 7 | $135 |
| Lilly USA, LLC | 8 | $129 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $123 |
| E.R. Squibb & Sons, L.L.C. | 6 | $122 |
Products named: DUPIXENT, CIBINQO, TREMFYA, RINVOQ, NEMLUVIO, Bimzelx, TALTZ, Sotyktu.
Industry payments across OK — which companies pay providers there.
